Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging

Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently over expressed...

Full description

Bibliographic Details
Main Authors: Linda K Mooberry, Nirupama Avinash Sabnis, Bhavani Nagarajan, Marlyn Panchoo, Andras G Lacko
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00466/full
id doaj-84291063d67b48778800510d0f38ac7b
record_format Article
spelling doaj-84291063d67b48778800510d0f38ac7b2020-11-24T21:39:41ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122016-12-01710.3389/fphar.2016.00466224205Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imagingLinda K Mooberry0Nirupama Avinash Sabnis1Bhavani Nagarajan2Marlyn Panchoo3Andras G Lacko4Andras G Lacko5University of North Texas Health Science CenterUniversity of North Texas Health Science CenterUniversity of North Texas Health Science CenterUniversity of North Texas Health Science CenterUniversity of North Texas Health Science CenterUniversity of North Texas Health Science CenterMalignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently over expressed by most tumor cells. In addition, the SR-B1 receptor has been shown to serve as a potential gateway for the delivery of therapeutic agents when reconstituted high density lipoprotein (rHDL) nanoparticles are used for their transport to cancer cells and tumors. Opportunities for the development of new technologies, particularly in the areas of cancer therapy and tumor imaging are discussed.http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00466/fullDrug Delivery Systemstumor imagingindividual therapySR-B1gateway for theranostics
collection DOAJ
language English
format Article
sources DOAJ
author Linda K Mooberry
Nirupama Avinash Sabnis
Bhavani Nagarajan
Marlyn Panchoo
Andras G Lacko
Andras G Lacko
spellingShingle Linda K Mooberry
Nirupama Avinash Sabnis
Bhavani Nagarajan
Marlyn Panchoo
Andras G Lacko
Andras G Lacko
Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
Frontiers in Pharmacology
Drug Delivery Systems
tumor imaging
individual therapy
SR-B1
gateway for theranostics
author_facet Linda K Mooberry
Nirupama Avinash Sabnis
Bhavani Nagarajan
Marlyn Panchoo
Andras G Lacko
Andras G Lacko
author_sort Linda K Mooberry
title Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
title_short Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
title_full Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
title_fullStr Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
title_full_unstemmed Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
title_sort targeting the sr-b1 receptor as a gateway for cancer therapy and tumor imaging
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2016-12-01
description Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently over expressed by most tumor cells. In addition, the SR-B1 receptor has been shown to serve as a potential gateway for the delivery of therapeutic agents when reconstituted high density lipoprotein (rHDL) nanoparticles are used for their transport to cancer cells and tumors. Opportunities for the development of new technologies, particularly in the areas of cancer therapy and tumor imaging are discussed.
topic Drug Delivery Systems
tumor imaging
individual therapy
SR-B1
gateway for theranostics
url http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00466/full
work_keys_str_mv AT lindakmooberry targetingthesrb1receptorasagatewayforcancertherapyandtumorimaging
AT nirupamaavinashsabnis targetingthesrb1receptorasagatewayforcancertherapyandtumorimaging
AT bhavaninagarajan targetingthesrb1receptorasagatewayforcancertherapyandtumorimaging
AT marlynpanchoo targetingthesrb1receptorasagatewayforcancertherapyandtumorimaging
AT andrasglacko targetingthesrb1receptorasagatewayforcancertherapyandtumorimaging
AT andrasglacko targetingthesrb1receptorasagatewayforcancertherapyandtumorimaging
_version_ 1725929886254628864